Convenio de Suministro de Fármacos No Incorporados en CENABAST 3
Conforme a la Ley de Compras Públicas, su Reglamento y modificaciones, el Hospital Provincial de Ovalle llama a licitación pública a empresas o proveedores del rubro, personas naturales o jurídicas, chilenas o extranjeras, así como a Uniones Temporales de Proveedores, para celebrar un “CONVENIO DE SUMINISTRO DE FÁRMACOS NO INCORPORADOS EN CENABAST 3”, por un período de 24 (veinticuatro) meses o hasta agotar el presupuesto disponible debidamente autorizado, para un oportuno y adecuado suministro de estos fármacos para tratamientos en pacientes que así lo requieran.
20 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058045-411-SE26 | 23-04-2026 | Guillermo Harding y Compania Limitada | $506.940 |
| 1058045-390-SE26 | 22-04-2026 | Laboratorios Andromaco S.A. | $533.715 |
| 1058045-286-SE26 | 25-03-2026 | Laboratorio Chile S.A. | $851.731 |
| 1058045-288-SE26 | 25-03-2026 | Guillermo Harding y Compania Limitada | $506.940 |
| 1058045-247-SE26 | 06-03-2026 | Laboratorio Chile S.A. | $851.731 |
| 1058045-229-SE26 | 26-02-2026 | Etex Farmaceutica Limitada | $345.695 |
| 1058045-206-SE26 | 19-02-2026 | Faes Farma Chile Salud y Nutricion Limitada | $424.116 |
| 1058045-153-SE26 | 12-02-2026 | Etex Farmaceutica Limitada | $768.978 |
| 1058045-89-SE26 | 19-01-2026 | Laboratorios Andromaco S.A. | $139.230 |
| 1058045-77-SE26 | 19-01-2026 | Laboratorio Chile S.A. | $851.731 |
| 1058045-21-SE26 | 15-01-2026 | Laboratorio Chile S.A. | $1.203.804 |
| 1058045-23-SE26 | 15-01-2026 | Faes Farma Chile Salud y Nutricion Limitada | $424.116 |
| 1058045-22-SE26 | 13-01-2026 | Guillermo Harding y Compania Limitada | $420.546 |
| 1058045-1244-SE25 | 22-12-2025 | Guillermo Harding y Compania Limitada | $506.940 |
| 1058045-1239-SE25 | 22-12-2025 | Laboratorio Chile S.A. | $564.060 |
| 1058045-1168-SE25 | 24-11-2025 | Etex Farmaceutica Limitada | $207.417 |
| 1058045-1100-SE25 | 28-10-2025 | Laboratorio Chile S.A. | $141.015 |
| 1058045-1079-SE25 | 21-10-2025 | Guillermo Harding y Compania Limitada | $339.031 |
| 1058045-971-SE25 | 08-09-2025 | Guillermo Harding y Compania Limitada | $448.481 |
| 1058045-687-SE25 | 27-05-2025 | Laboratorio Chile S.A. | $1.847.011 |
| 1058045-607-SE25 | 23-04-2025 | Etex Farmaceutica Limitada | $4.613.868 |
| 1058045-433-SE25 | 16-04-2025 | Guillermo Harding y Compania Limitada | $305.128 |
| 1058045-432-SE25 | 16-04-2025 | Galenicum Health Chile SpA | $229.808 |
| 1058045-434-SE25 | 16-04-2025 | Pharmatech Chile SpA | $416.500 |
| 1058045-397-SE25 | 26-03-2025 | Guillermo Harding y Compania Limitada | $775.618 |
| 1058045-398-SE25 | 26-03-2025 | Laboratorio Chile S.A. | $2.006.340 |
| 1058045-370-SE25 | 25-03-2025 | Etex Farmaceutica Limitada | $186.675 |
| 1058045-317-SE25 | 26-02-2025 | Etex Farmaceutica Limitada | $82.967 |
| 1058045-220-SE25 | 10-02-2025 | Guillermo Harding y Compania Limitada | $1.055.078 |
| 1058045-218-SE25 | 06-02-2025 | Laboratorio Chile S.A. | $3.893.799 |
| 1058045-219-SE25 | 06-02-2025 | Laboratorios Andromaco S.A. | $742.560 |
| 1058045-120-SE25 | 16-01-2025 | Laboratorio Chile S.A. | $838.950 |
| 1058045-121-SE25 | 16-01-2025 | Guillermo Harding y Compania Limitada | $305.128 |
| 1058045-16-SE25 | 07-01-2025 | Guillermo Harding y Compania Limitada | $575.960 |
| 1058045-1223-SE24 | 31-12-2024 | Laboratorios Andromaco S.A. | $371.280 |
| 1058045-1039-SE24 | 31-12-2024 | Pharmatech Chile SpA | $957.950 |
| 1058045-1217-SE24 | 31-12-2024 | Comercializadora e Inversiones Ghaleno Limitada | $4.873.050 |
| 1058045-1220-SE24 | 31-12-2024 | Laboratorio Chile S.A. | $366.639 |
| 1058045-1228-SE24 | 31-12-2024 | Difem Laboratorios S.A. | $1.231.650 |
| 1058045-1229-SE24 | 31-12-2024 | Galenicum Health Chile SpA | $947.088 |
| 1058045-1201-SE24 | 30-12-2024 | Laboratorio Chile S.A. | $1.071.000 |
| 1058045-1187-SE24 | 17-12-2024 | Guillermo Harding y Compania Limitada | $851.659 |
| 1058045-908-SE24 | 21-11-2024 | Laboratorio Chile S.A. | $535.500 |
| 1058045-1092-SE24 | 14-11-2024 | Etex Farmaceutica Limitada | $103.709 |
| 1058045-688-SE24 | 30-10-2024 | Galenicum Health Chile SpA | $250.700 |
| 1058045-689-SE24 | 30-10-2024 | Guillermo Harding y Compania Limitada | $506.940 |
| 1058045-877-SE24 | 30-10-2024 | Faes Farma Chile Salud y Nutricion Limitada | $345.576 |
| 1058045-1040-SE24 | 22-10-2024 | Comercializadora e Inversiones Ghaleno Limitada | $4.176.900 |
| 1058045-778-SE24 | 22-10-2024 | Guillermo Harding y Compania Limitada | $654.500 |
| 1058045-878-SE24 | 12-09-2024 | Pharmatech Chile SpA | $1.874.250 |
| 1058045-776-SE24 | 10-07-2024 | Faes Farma Chile Salud y Nutricion Limitada | $188.496 |
| 1058045-623-SE24 | 27-06-2024 | Etex Farmaceutica Limitada | $82.967 |
| 1058045-639-SE24 | 03-06-2024 | Guillermo Harding y Compania Limitada | $235.620 |
| 1058045-667-SE24 | 31-05-2024 | Laboratorio Chile S.A. | $91.547 |
| 1058045-598-SE24 | 06-05-2024 | Etex Farmaceutica Limitada | $4.913.769 |
Fuente original:ficha mercadopublico.cl
